Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4868-4871

  Hesselink, A T ^a   Van Den Brule, A J C ^b   Groothuismink, Z M A ^a   Molano, M ^a   Berkhof, J ^a   Meijer, C J L M ^a   Snijders, P J F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; COMPARATIVE STUDY; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INTERMETHOD COMPARISON; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CYTOLOGY; VIRUS LOAD;

CERVIX UTERI; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TAQ POLYMERASE; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 24744462312     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4868-4871.2005     Document Type: Article

References (14)

1. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
2. Bulk, S., F. J. van Kemenade, L. Rozendaal, and C. J. Meijer. 2004. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J. Clin. Pathol. 57:388-393.
3. Cuzick, J., G. Terry, L. Ho, T. Hollingworth, and M. Anderson. 1992. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]. Lancet 339:959-960.
4. Gravitt, P. E., R. D. Burk, A. Lorincz, R. Herrero, A. Hildesheim, M. E. Sherman, M. C. Bratti, A. C. Rodriguez, K. J. Helzlsouer, and M. Schiffman. 2003. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol. Biomark. Prev. 12:477-484.
5. Jacobs, M. V., P. J. Snijders, A. J. van den Brule, T, J. Helmerhorst, C. J. Meijer, and J. M. Walboomers. 1997. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:791-795.
6. Josefsson, A. M., P. K. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, P. K. Andersen, M. Melbye, H. O. Adami, and U. B. Gyllensten. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355:2189-2193.
7. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
8. Pretet, J. L., V. Dalstein, S. Monnier-Benoit, S. Delpeut, and C. Mougin. 2004. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J. Clin. Virol. 31:140-147.
9. Snijders, P. J., A. J. van den Brule, and C. J. Meijer. 2003. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J. Pathol. 201:1-6.
10. Stevens, S. J., S. A. Verkuijlen, A. J. Brule, and J. M. Middeldorp. 2002. Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens. J. Clin. Microbiol. 40:3986-3992.
11. Swan, D. C., R. A. Tucker, G. Tortolero-Luna, M. F. Mitchell, L. Wideroff, E. R. Unger, R. A. Nisenbaum, W. C. Reeves, and J. P. Icenogle. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1030-1034.
12. van den Brule, A. J., R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. Meijer, and P. J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
13. van Duin, M., P. J. Snijders, H. F. Schrijnemakers, F. J. Voorhorst, L. Rozendaal, M. A. Nobbenhuis, A. J. van den Brule, R. H. Verheijen, T. J. Helmerhorst, and C. J. Meijer. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer 98:590-595.
14. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.